Literature DB >> 17884086

Mitochondrial respiration and membrane potential after low-flow ischemia are not affected by ischemic preconditioning.

Kerstin Boengler1, Petra Gres, Giuliano Dodoni, Ina Konietzka, Fabio Di Lisa, Gerd Heusch, Rainer Schulz.   

Abstract

Mitochondrial function following prolonged ischemia and subsequent reperfusion is better preserved by ischemic preconditioning (IP). In the present study, we analyzed whether or not IP has an impact on mitochondrial function at the end of a sustained ischemic period. Göttinger minipigs were subjected to 90-min low-flow ischemia without (n=5) and with (n=5) a preconditioning cycle of 10-min ischemia and 15-min reperfusion. Mitochondria were isolated from the ischemic or preconditioned anterior wall (AW) and the control posterior wall (PW) at the end of ischemia. Basal mitochondrial respiration was not different between AW and PW. The ADP-stimulated (state 3) respiration in AW mitochondria compared to PW mitochondria was equally decreased in non-preconditioned and preconditioned pigs. The uncoupled respiration as well as the membrane potential (rhodamine 123 fluorescence) were not significantly different between groups. However, the recovery of the membrane potential (Delta rhodamine 123 fluorescence/s) after the addition of ADP was delayed in mitochondria obtained from AW compared to PW, both in non-preconditioned and in preconditioned pig hearts. Neither the amount of marker proteins for complexes of the electron transport chain nor the level of reactive oxygen species were affected by ischemia without or with IP. State 3 respiration and recovery of membrane potential were impaired in pig mitochondria after 90 min of low-flow ischemia. IP did not improve mitochondrial function during ischemia. Therefore, the preservation of mitochondrial function by IP may occur during reperfusion rather than during the sustained ischemic period.

Entities:  

Mesh:

Year:  2007        PMID: 17884086     DOI: 10.1016/j.yjmcc.2007.08.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction.

Authors:  Ning Li; Thierry Brun; Miriam Cnop; Daniel A Cunha; Decio L Eizirik; Pierre Maechler
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

2.  Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects.

Authors:  Susanne Rohrbach; Muhammad Aslam; Bernd Niemann; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

3.  Mitochondria: from basic biology to cardiovascular disease.

Authors:  Elizabeth Murphy; Donald Bers; Rosario Rizzuto
Journal:  J Mol Cell Cardiol       Date:  2009-03-14       Impact factor: 5.000

Review 4.  Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning.

Authors:  Satoshi Matsuzaki; Pamela A Szweda; Luke I Szweda; Kenneth M Humphries
Journal:  Adv Drug Deliv Rev       Date:  2009-08-26       Impact factor: 15.470

5.  Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left ventricular dysfunction.

Authors:  Renaud Tissier; Nicolas Couvreur; Bijan Ghaleh; Patrick Bruneval; Fanny Lidouren; Didier Morin; Roland Zini; Alain Bize; Mourad Chenoune; Marie-France Belair; Chantal Mandet; Martine Douheret; Jean-Luc Dubois-Rande; James C Parker; Michael V Cohen; James M Downey; Alain Berdeaux
Journal:  Cardiovasc Res       Date:  2009-02-05       Impact factor: 10.787

6.  Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption.

Authors:  Kerstin Boengler; Marisol Ruiz-Meana; Sabine Gent; Elvira Ungefug; Daniel Soetkamp; Elisabet Miro-Casas; Alberto Cabestrero; Celia Fernandez-Sanz; Martina Semenzato; Fabio Di Lisa; Susanne Rohrbach; David Garcia-Dorado; Gerd Heusch; Rainer Schulz
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.